Dolasetron Mesylate Hydrate

甲磺酸多拉司琼水合物

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDolasetron Mesylate Hydrate
Drug Alias Namedolasetronum多拉斯琼多拉司琼多拉司琼甲磺酸盐一水合物Anemet +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsVomitingNausea
Global Approved IndicationsVomitingNausea
Approved Indications in ChinaVomitingNausea
Original Approved Country/TerritoryUnited States
Original Approved Date1997/09/11
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesLiaoning Haisco Pharmaceutical Co Ltd
Inactive CompaniesUs Pharm Holdings
Active IndicationsVomitingNausea
Inactive IndicationsN/A

Other Information

ATC CodeA04AA04
Related LinksWikipediaDrugBankKEGG